Skip to content
Technician in full personal protective equipment carrying a sample rack through a clean laboratory
All insights

USP 797 and 800 Inspection Readiness: An Operator's Checklist

Inspection readiness is not a binder you assemble the week before. It is whether your daily operation produces the evidence on its own. Here is what inspectors actually ask to see.

Pinnacle 503A Advisors · August 12, 2026 · 5 min read

Inspection readiness is not a state you enter the week before an inspection. It is a property of how the pharmacy runs the rest of the year. A pharmacy that operates well produces inspection evidence as a byproduct; a pharmacy that does not will spend the week before assembling a binder that an experienced inspector can see through in about twenty minutes.

The useful question is not "do we have a document for this?" It is "can we demonstrate this was true on a random Tuesday four months ago?" Everything below is organized around that question.

This is an operator's working checklist, not regulatory advice. USP chapters and state board requirements change, and states enforce them differently. Verify current requirements against your own state board and the current USP text.

The most common EM finding is not a missing sample. It is samples with no trending, no action levels, and no evidence anyone looked at the results.

What should exist:

  • A written sampling plan covering viable air, surface and personnel sampling, with defined locations and frequencies — and a documented rationale for why those locations.
  • Action and alert levels defined in advance, not decided after a result comes back high.
  • Trend analysis over time. An inspector wants to see that you know whether you are drifting, which a stack of individual reports cannot show.
  • Documented responses to excursions. Every out-of-limit result needs an investigation, a corrective action and a verification that it worked.
  • Certification records for hoods and the cleanroom, current and on file.

The single question to ask yourself: when a result exceeded the action level, what happened next, and can you show it? If the honest answer is "we resampled and it was fine," that is a finding waiting to happen.

Personnel: competency, not attendance

Training records are inspection evidence, and they are where growing pharmacies fall behind fastest — someone is hired during a busy stretch and the paperwork never catches up.

What should exist:

  • Initial and ongoing competency assessments for every person who compounds, with the ongoing cadence USP requires for your category of compounding.
  • Media fill records appropriate to sterile compounding, per person, current.
  • Gloved fingertip and garbing assessments, documented per person, with results.
  • Aseptic technique observation by a qualified observer, recorded.
  • Records that match your actual roster. A file for someone who left two years ago and none for the tech hired in March is a very visible problem.

The distinction that matters: attendance records prove someone was present. Competency records prove they can do it. Inspectors want the second.

USP 800: containment you can demonstrate

USP 800 findings tend to cluster around hazardous drug handling being described rather than practiced.

What should exist:

  • A current assessment of risk covering the hazardous drugs you actually handle, reviewed at a defined interval.
  • A hazardous drug list reconciled against what is genuinely on your shelves right now.
  • Containment controls — C-PEC, C-SEC, negative pressure, documented airflow — with verification records, not just a description.
  • PPE requirements defined per activity, with evidence of use and disposal.
  • Deactivation, decontamination, cleaning and disinfection procedures that specify agents and frequencies, with completion records.
  • Spill procedures and a stocked spill kit, plus documented staff training on them.

The practical test: pick one hazardous drug you handle and walk it end to end — receipt, storage, compounding, transport, disposal. If any step is "we would do X" rather than "here is the record showing we did X," that is your gap.

Documentation: the reviewer was not there

Batch records get written by people who know what happened. They get read by people who do not, sometimes years later.

What should exist:

  • Master formulation records for every preparation, current and approved.
  • Compounding records for every batch, complete, with actual values rather than pre-filled expected ones.
  • Component traceability — lot numbers, expiration dates, supplier — sufficient to reconstruct a batch from the record alone.
  • BUD assignment with a documented basis. "We always use 30 days" is not a basis.
  • Release criteria and a documented release decision with a name attached.

The test: hand a completed batch record to someone who was not involved and ask them to describe what happened. Every question they cannot answer from the document is a gap.

Quality systems: does anything close?

The quality system is where inspectors look to see whether the pharmacy corrects itself or merely records problems.

What should exist:

  • Deviation and nonconformance handling with investigation, root cause and disposition.
  • CAPA that closes, with effectiveness verified rather than assumed.
  • Change control for facility, equipment, process and formulation changes.
  • Complaint handling with trending.
  • Internal audits or mock inspections on a defined cadence, with findings tracked to closure.

Open items from more than a few months ago are the clearest possible signal that the system records problems but does not resolve them. That single observation shapes how an inspector reads everything else.

The week-before checklist is the wrong instinct

If your preparation for an inspection is a scramble, the scramble itself is the finding — it means the operation does not produce this evidence normally, so what an inspector sees is an unusual state rather than your real one. They are good at telling the difference.

The alternative is a quarterly rhythm: EM trends reviewed, competencies current, open CAPAs closing, one mock walkthrough of one process end to end. Done routinely, none of it is a scramble, and readiness stops being an event.

That rhythm is an operations responsibility. Where it usually breaks is not knowledge — most 503A teams know what USP requires — but ownership: nobody's job is to make sure it happens every quarter while everything else is also happening. That is the seat a fractional COO fills, and it is why inspection readiness tends to follow from operational structure rather than from compliance effort alone.

If you want an outside read before a board inspection, a mock inspection will find in a day what would otherwise be found on the record. A consultation is the place to start.

Want this run properly, not just documented?

Request a consultation to discuss your pharmacy and where the operational gaps are.

Request Consultation